Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
BACKGROUND: Although malaria treatment aims primarily to eliminate the asexual blood stages that cause illness, reducing the carriage of gametocytes is critical for limiting malaria transmission and the spread of resistance. METHODS: Clinical and parasitological responses to the fixed-dose combinat...
Main Authors: | Barnes, K, Little, F, Mabuza, A, Mngomezulu, N, Govere, J, Durrheim, D, Roper, C, Watkins, B, White, N |
---|---|
Format: | Conference item |
Published: |
2008
|
Similar Items
-
Sulfadoxine-pyrimethamine pharmacokinetics in malaria: pediatric dosing implications.
by: Barnes, K, et al.
Published: (2006) -
Sulfadoxine-pyrimethamine for the treatment of malaria.
by: White, N
Published: (1991) -
Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
by: Peto, T, et al.
Published: (1985) -
Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon
by: Basco Leonardo K., et al.
Published: (2002-01-01) -
A randomized comparison of oral chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in Laos.
by: Mayxay, M, et al.
Published: (2003)